FDA Approved: MYFEMBREE — Original Application (Sumitomo Pharma America, Inc)

View source ↗

Summary

FDA approved MYFEMBREE, a fixed-dose combination of relugolix, estradiol hemihydrate, and norethindrone acetate, for the treatment of heavy menstrual bleeding a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• MYFEMBREE (relugolix, estradiol hemihydrate, and norethindrone acetate)

Snippet

ORIG AP for MYFEMBREE (RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE)